Trials / Completed
CompletedNCT02376868
Maestro Agreement and Precision Study II
Topcon 3D OCT-1 Maestro Agreement and Precision Study II
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Assess the repeatability and agreement of the Optic Disc Parameters, Retinal Nerve Fiber Layer (RNFL) Thickness, Full Retinal Thickness, and Ganglion Cell Thickness between the Maestro and iVue OCT devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3D OCT-1 Maestro | OCT machines used for diagnostic purposes |
| DEVICE | iVue | OCT machines used for diagnostic purposes |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-03-03
- Last updated
- 2022-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02376868. Inclusion in this directory is not an endorsement.